1. Middleton, B.F., Jones, M.A., Waddington, C.S., Danchin, M., McCallum, C., Gallagher, S., ... & Snelling, T. (2019). The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis. BMJ Open, 9(11), e032549 https://bmjopen.bmj.com/content/9/11/e032549.abstract
  2. Jones, M. A., Graves, T., Middleton, B., Totterdell, J., Snelling, T. L., & Marsh, J. A. (2020). The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan. Trials, 21(1), 1-19. https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04602-w
  3. Middleton, B. F., Danchin, M., Jones, M. A., Leach, A. J., Cunliffe, N., Kirkwood, C. D., ... & Snelling, T. L. (2022). Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical Trial. The Journal of Infectious Diseases, 20, 1-8. https://ris.cdu.edu.au/ws/files/56002370/jiac038.pdf